Latest filing published 10 Aug 2026 for Charles River Laboratories International, INC., €649k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Victoria L. Creamer, listed as senior executive, appears in our data through filings on Charles River Laboratories International, Inc. shares, published by SEC (Form 4). In total, 29 filings cover trades dated from 28 May 2021 to 6 August 2026.
Every open-market trade on record is a sale: 2 sales worth €2.1M. Outside the open market, there are 24 share grants and 3 option exercises. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 10 August 2026, the filings show an option exercise worth €649k in Charles River Laboratories International, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 29 declarations